Market Cap 219.20M
Revenue (ttm) 0.00
Net Income (ttm) -57.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 524,500
Avg Vol 694,062
Day's Range N/A - N/A
Shares Out 56.20M
Stochastic %K 33%
Beta 1.45
Analysts Strong Sell
Price Target $26.57

Company Profile

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving pare...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 844 0337
Address:
345 Park Avenue South, 3rd Floor, New York, United States
Rolo2024
Rolo2024 Jun. 14 at 11:52 PM
$TARA Whats happening with TARA why the sudden increase? Any news articles?
0 · Reply
Shawnjo44
Shawnjo44 Jun. 14 at 12:07 AM
$TARA I think we see something here next week.
0 · Reply
MadStockAlerts
MadStockAlerts Jun. 13 at 9:29 PM
$TARA is quietly building a case that's hard to look past.
0 · Reply
UpAndDownUpAndDown
UpAndDownUpAndDown Jun. 13 at 2:05 PM
$TARA she’s about to explode Monday with news.
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 11:40 PM
$TARA not exactly explosive, but very difficult to ignore.
0 · Reply
Rolo2024
Rolo2024 Jun. 12 at 10:50 PM
$TARA Wow! Just as I posted it updated to $4.28!!! Strange delays going on.
0 · Reply
Rolo2024
Rolo2024 Jun. 12 at 10:48 PM
$TARA My Schwab account shows TARA at $4.28 everywhere else its $3.98?! Schwab error?
0 · Reply
Rolo2024
Rolo2024 Jun. 12 at 10:41 PM
$TARA Whats happening with TARA today! Why the big upswing? I don’t see any news?
0 · Reply
Gurss
Gurss Jun. 11 at 9:51 PM
0 · Reply
Quantumup
Quantumup Jun. 10 at 11:26 AM
BofA⬆️ $TYRA's PT to $42 (was $37), reiterated Buy and said: After a strong start to 2026, sentiment on Tyra has cooled despite seemingly little change to the story (since May: TYRA -25% vs. NBI flat). CGON URGN $JNJ ENGN IBRX $TARA Here's what BofA went on to say: https://x.com/Quantumup1/status/2064669900359016705?s=20
1 · Reply
Latest News on TARA
Protara Therapeutics Transcript: KOL event

May 19, 2026, 4:30 PM EDT - 26 days ago

Protara Therapeutics Transcript: KOL event


Protara Therapeutics Slides: KOL event

May 19, 2026, 4:30 PM EDT - 26 days ago

Protara Therapeutics Slides: KOL event


Protara Therapeutics files $300M mixed securities shelf

2026-05-14T10:24:59.000Z - 4 weeks ago

Protara Therapeutics files $300M mixed securities shelf


Protara Therapeutics reports Q1 EPS (31c), consensus (37c)

2026-05-13T16:20:33.000Z - 4 weeks ago

Protara Therapeutics reports Q1 EPS (31c), consensus (37c)


Protara Therapeutics Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 4 weeks ago

Protara Therapeutics Earnings release: Q1 2026


Protara Therapeutics Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 4 weeks ago

Protara Therapeutics Quarterly report: Q1 2026


Protara Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 6 weeks ago

Protara Therapeutics Proxy statement: Proxy filing


Protara Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 6 weeks ago

Protara Therapeutics Proxy statement: Proxy filing


Protara Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Protara Therapeutics Proxy statement: Proxy filing


Protara Therapeutics reports Q4 EPS (37c), consensus (31c)

2026-03-10T12:11:59.000Z - 3 months ago

Protara Therapeutics reports Q4 EPS (37c), consensus (31c)


Protara Therapeutics sees cash runway into 2028

2026-03-10T12:11:32.000Z - 3 months ago

Protara Therapeutics sees cash runway into 2028


Protara Therapeutics Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 3 months ago

Protara Therapeutics Annual report: Q4 2025


Protara Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 3 months ago

Protara Therapeutics Earnings release: Q4 2025


Protara Therapeutics initiated with an Overweight at JPMorgan

2026-03-04T10:10:45.000Z - 3 months ago

Protara Therapeutics initiated with an Overweight at JPMorgan


Protara Therapeutics Transcript: Study update

Feb 24, 2026, 8:00 AM EST - 3 months ago

Protara Therapeutics Transcript: Study update


Protara Therapeutics Press release: Study update

Feb 24, 2026, 8:00 AM EST - 3 months ago

Protara Therapeutics Press release: Study update


Protara Therapeutics Slides: Study update

Feb 24, 2026, 8:00 AM EST - 3 months ago

Protara Therapeutics Slides: Study update


Protara Therapeutics management to meet with Oppenheimer

2026-02-02T12:46:15.000Z - 4 months ago

Protara Therapeutics management to meet with Oppenheimer


Protara Therapeutics highlights recent updates, 2026 milestones

2026-01-12T12:20:09.000Z - 5 months ago

Protara Therapeutics highlights recent updates, 2026 milestones


Protara Therapeutics Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 5 months ago

Protara Therapeutics Slides: Corporate presentation


Protara Announces Closing of $75 Million Public Offering

Dec 8, 2025, 4:05 PM EST - 6 months ago

Protara Announces Closing of $75 Million Public Offering


Protara Therapeutics down 18% at $5.66 after equity offering

2025-12-05T13:05:44.000Z - 6 months ago

Protara Therapeutics down 18% at $5.66 after equity offering


Protara Announces Pricing of $75 Million Public Offering

Dec 4, 2025, 10:03 PM EST - 6 months ago

Protara Announces Pricing of $75 Million Public Offering


Protara Announces Proposed Public Offering

Dec 4, 2025, 4:15 PM EST - 6 months ago

Protara Announces Proposed Public Offering


Protara Therapeutics Transcript: Study Update

Dec 3, 2025, 8:30 AM EST - 6 months ago

Protara Therapeutics Transcript: Study Update


Protara Therapeutics Press release: Study Update

Dec 3, 2025, 8:30 AM EST - 6 months ago

Protara Therapeutics Press release: Study Update


Protara Therapeutics Slides: Study Update

Dec 3, 2025, 8:30 AM EST - 6 months ago

Protara Therapeutics Slides: Study Update


Protara Therapeutics Transcript: Study Update

Nov 19, 2025, 8:30 AM EST - 7 months ago

Protara Therapeutics Transcript: Study Update


Protara Therapeutics Press release: Study Update

Nov 19, 2025, 8:30 AM EST - 7 months ago

Protara Therapeutics Press release: Study Update


Protara Therapeutics Slides: Study Update

Nov 19, 2025, 8:30 AM EST - 7 months ago

Protara Therapeutics Slides: Study Update


Protara Therapeutics Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 7 months ago

Protara Therapeutics Earnings release: Q3 2025


Protara Therapeutics Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 7 months ago

Protara Therapeutics Quarterly report: Q3 2025


Protara Therapeutics Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Protara Therapeutics Quarterly report: Q2 2025


Protara Therapeutics Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Protara Therapeutics Earnings release: Q2 2025


Protara Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Protara Therapeutics Quarterly report: Q1 2025


Protara Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Protara Therapeutics Earnings release: Q1 2025


Protara Therapeutics Transcript: Status Update

Apr 28, 2025, 8:30 AM EDT - 1 year ago

Protara Therapeutics Transcript: Status Update


Protara Therapeutics Press release: Status Update

Apr 28, 2025, 8:30 AM EDT - 1 year ago

Protara Therapeutics Press release: Status Update


Protara Therapeutics Slides: Status Update

Apr 28, 2025, 8:30 AM EDT - 1 year ago

Protara Therapeutics Slides: Status Update


Protara Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Protara Therapeutics Proxy statement: Proxy Filing


Protara Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Protara Therapeutics Proxy statement: Proxy Filing


Protara Therapeutics Earnings release: Q4 2024

Mar 5, 2025, 8:00 AM EST - 1 year ago

Protara Therapeutics Earnings release: Q4 2024


Protara Therapeutics Annual report: Q4 2024

Mar 5, 2025, 8:00 AM EST - 1 year ago

Protara Therapeutics Annual report: Q4 2024


Protara Therapeutics Slides: FY 2025

Jan 9, 2025, 6:00 PM EST - 1 year ago

Protara Therapeutics Slides: FY 2025


Protara Announces Closing of $100 Million Public Offering

Dec 11, 2024, 4:05 PM EST - 1 year ago

Protara Announces Closing of $100 Million Public Offering


Protara Announces Pricing of $100 Million Public Offering

Dec 9, 2024, 11:35 PM EST - 1 year ago

Protara Announces Pricing of $100 Million Public Offering


Protara Therapeutics Transcript: Study Update

Dec 5, 2024, 8:30 AM EST - 1 year ago

Protara Therapeutics Transcript: Study Update


Protara Therapeutics Press release: Study Update

Dec 5, 2024, 8:30 AM EST - 1 year ago

Protara Therapeutics Press release: Study Update


Protara Therapeutics Slides: Study Update

Dec 5, 2024, 8:30 AM EST - 1 year ago

Protara Therapeutics Slides: Study Update


Protara Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Protara Therapeutics Earnings release: Q3 2024


Protara Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Protara Therapeutics Quarterly report: Q3 2024


Protara Therapeutics Quarterly report: Q2 2024

Aug 6, 2024, 7:00 AM EDT - 2 years ago

Protara Therapeutics Quarterly report: Q2 2024


Protara Therapeutics Earnings release: Q2 2024

Aug 6, 2024, 7:00 AM EDT - 2 years ago

Protara Therapeutics Earnings release: Q2 2024


Protara Therapeutics Quarterly report: Q1 2024

May 2, 2024, 7:00 AM EDT - 2 years ago

Protara Therapeutics Quarterly report: Q1 2024


Protara Therapeutics Earnings release: Q1 2024

May 2, 2024, 7:00 AM EDT - 2 years ago

Protara Therapeutics Earnings release: Q1 2024


Protara Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Protara Therapeutics Proxy statement: Proxy Filing


Protara Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Protara Therapeutics Proxy statement: Proxy Filing


Rolo2024
Rolo2024 Jun. 14 at 11:52 PM
$TARA Whats happening with TARA why the sudden increase? Any news articles?
0 · Reply
Shawnjo44
Shawnjo44 Jun. 14 at 12:07 AM
$TARA I think we see something here next week.
0 · Reply
MadStockAlerts
MadStockAlerts Jun. 13 at 9:29 PM
$TARA is quietly building a case that's hard to look past.
0 · Reply
UpAndDownUpAndDown
UpAndDownUpAndDown Jun. 13 at 2:05 PM
$TARA she’s about to explode Monday with news.
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 11:40 PM
$TARA not exactly explosive, but very difficult to ignore.
0 · Reply
Rolo2024
Rolo2024 Jun. 12 at 10:50 PM
$TARA Wow! Just as I posted it updated to $4.28!!! Strange delays going on.
0 · Reply
Rolo2024
Rolo2024 Jun. 12 at 10:48 PM
$TARA My Schwab account shows TARA at $4.28 everywhere else its $3.98?! Schwab error?
0 · Reply
Rolo2024
Rolo2024 Jun. 12 at 10:41 PM
$TARA Whats happening with TARA today! Why the big upswing? I don’t see any news?
0 · Reply
Gurss
Gurss Jun. 11 at 9:51 PM
0 · Reply
Quantumup
Quantumup Jun. 10 at 11:26 AM
BofA⬆️ $TYRA's PT to $42 (was $37), reiterated Buy and said: After a strong start to 2026, sentiment on Tyra has cooled despite seemingly little change to the story (since May: TYRA -25% vs. NBI flat). CGON URGN $JNJ ENGN IBRX $TARA Here's what BofA went on to say: https://x.com/Quantumup1/status/2064669900359016705?s=20
1 · Reply
RakeTheProfit
RakeTheProfit Jun. 10 at 1:14 AM
$TARA this ticker is being slept on wayyyy too hard.
1 · Reply
Gurss
Gurss Jun. 5 at 9:08 PM
0 · Reply
Ramanda87
Ramanda87 Jun. 5 at 2:00 PM
$TARA several analysts at $25 on this POS and we haven’t seen shitt since it crashed…
1 · Reply
ProfitMaker4
ProfitMaker4 Jun. 4 at 1:46 PM
$TARA up 114% on my LT position and buying more at these levels, heavily oversold, ton of upside on positive FDA ruling, and strong inst ownership.
0 · Reply
amda
amda Jun. 3 at 3:50 PM
$TARA this is ridiculous. the ATM haircut is WAY overdone. I'm going to keep adding until it bounces!! (yes - I'm a glutton for punishment)
1 · Reply
amda
amda Jun. 3 at 1:54 PM
$TARA correction: $4.31 avg
0 · Reply
amda
amda Jun. 3 at 1:44 PM
$TARA and Oppenheimer at $28??
0 · Reply
amda
amda Jun. 3 at 1:42 PM
$TARA ok - let's try again. loaded the boat at $3.31 avg. can JPM be THAT wrong with a $27 target????
0 · Reply
baralos
baralos Jun. 2 at 8:52 PM
$TARA $TARA old that crap, good luck folks
0 · Reply
UpAndDownUpAndDown
UpAndDownUpAndDown Jun. 2 at 5:50 PM
$TARA every analyst is over $25. And we sit at 4 bucks. This is going up soon. Hold on.
0 · Reply
amda
amda Jun. 2 at 1:38 PM
$TARA wtf is going on here??
1 · Reply
pablo4
pablo4 May. 29 at 12:00 AM
$TARA @Elite000 Thanks for all of that. There is still value in NMIBC, I believe, but it's not likely to be the driver here....but I've already commented several days back that I agree with the content of the article linked in the below post I'm resharing to you here. In this regard, I think TARA continues to have a strong pipeline that makes it a valuable stock to own. It remains a rational investment and I think the 7 analysts, who are all following and understand the NMIBC market well, are probably sizing TARA up as one that will have its centrality on rare drug treatments like LM and that even choline chloride will be its real future. I think it's a mistake to make TARA all about NMIBC but it seems the stock market is pricing it that way. JMO
2 · Reply